Swallowable metal microrobots that transform shape to deliver drugs and collect tissue samples before safely dissolving could ...

A new study from VIB and KU Leuven has revealed that Parkinson's disease comprises five distinct molecular subtypes, each requiring tailored therapeutic approaches.

Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...

Researchers at Tokyo University of Science have developed a safer synthetic route to β-heteroatom-substituted diazo esters, ...

Cryo-expansion microscopy has enabled researchers to visualise the three-dimensional organisation of cytotoxic T lymphocytes ...

Researchers have discovered that DNA wrapped around nucleosomes exists in multiple partially open states rather than simply ...

Researchers have developed a dual-mechanism compound that significantly extended survival in preclinical pancreatic cancer ...

Drug Target Review has launched an updated website to improve access to content across early-stage drug discovery, alongside ...

Researchers at the University of Houston have identified epithelial stress signalling as a key driver of Crohn's disease and ...

For years, AI drug discovery has been judged on benchmark performance. Now, a set of studies shows what happens when those ...

Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

VIB-VUB researchers have developed a patient-relevant lung adenocarcinoma model combined with SEPARATE-Seq technology to ...